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BACKGROUND: Infection is a common cause of morbidity and mortality in burn patients. Clinical 
diagnosis of bacteremia and/or sepsis in burn patients is difficult for a number of reasons. It could be 
symptomatic and/or asymptomatic as a result of immune deficiency secondary to thermal injury. 
METHODS:  A cross sectional study was conducted at Yekatit 12 Hospital Burn Center.  Blood specimen 
and wound swab were collected from burn patients and were cultured by conventional method. 
Sensitivity/susceptibility pattern of the isolates was determined by disc diffusion method. Some of the risk 
factors of bacteremia like prior antibiotic use and total body surface area burn were also determined.  
RESULTS: Fifty patients were enrolled in the study of whom 21(42%) were found bacteremic. Five 
different bacteria were isolated from blood specimen. Coagulase negative Staphylococci, 9(42.8%), S. 
aureus, 8(38.2%), Bacillus spps, 2(9.52%), K. pneumoniae, 1(4.8%), and P. aeruginosa, 1(4.8%), were 
frequent isolates. From wound swab, S. aureus, (34.04%), and P. aeruginosa, (31.8%), were 
predominant. Antimicrobial resistance was observed for Ampicillin, (77.4%), Doxycycline, (74.0), 
Nalidixic acid, (70.5%), Penicillin G, (68.2%), and tetracycline, (67.5%). Total body surface area of burn 
≥ 15% was found as a risk factor for bacteremia. 
CONCLUSION: Bacteremia was detected at a rate of 42% among burn patients. Frequent isolates were 
S. aureus, (34.04%), and P. aeruginosa, (31.8%).  About 82.16% of the isolates showed multiple 
resistances. In light of our findings, regular antibiotic resistance test has to be done for each patient in 
order to select an appropriate antimicrobial agent. 




INTRODUCTION                                                                                                  
 
Burn wound infection is one of the most common 
causes of mortality and morbidity in burn patients 
(1). Major burn can be defined as any burn that 
requires intravenous resuscitation fluid or covers 
10% of body surface area in children and 15% of 
the body surface area in adults; and/or also burn 
that involves the air way (2-6). 
The frequency and gravity of septic complications 
in seriously ill burn patients impose the need for 
an accurate diagnostic and therapeutic approach. 
The microbiological monitoring of surface swabs 
and biopsies from burn wounds provide precise 
information as about the type of infection and the 
bacterial charge, but they give no indication of the 
depth of the infection (7-12). Microbiological 
investigation of superficial swabs should therefore 
be complemented with histological examination in 
order to detect possible presence of 
microorganism beneath the eschar. However, it is 
time-consuming and expensive, making it 
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impractical as a routine diagnostic technique; 
diagnosis of infection therefore relies on clinical 
parameters with the aid of blood and surface or 
tissue/biopsy cultures to identify the likely 
pathogen (13-17). 
Infection in burn patient is a leading cause of 
morbidity and mortality and it continues to be the 
challenging concern; the importance of preventing 
infection has been recognized in organized burn 
care centers starting from its inception. These 
included strict asceptic techniques, use of sterile 
gloves and dressing materials, wearing masks for 
dressing changes and special separation of 
patients, using private rooms (14).  
Clinical diagnosis of bacteremia and/or sepsis 
is difficult for a number of reasons. It could be 
symptomatic and/or may be asymptomatic as a 
result of immune deficiency secondary to thermal 
injury, malnutrition, anemia (reperfusion 
impaired), and damage to barriers 
(immunological) (15, 16). Periodical culturing and 
surveillance of potential microorganisms and their 
sensitivity/susceptibility pattern may alert early 
management and possible decrease in morbidity 
and mortality of burn patients from septicemia. 
The nature of microbial colonization of the 
wound, flora changes, and antimicrobial 
sensitivity profiles should be taken in to 
consideration in using empirical antimicrobial 
therapy for burn patients. This study was 
conducted to determine bacteremia, bacterial 
profile, and antimicrobial susceptibility pattern of 
bacterial isolates.   
 MATERIALS AND METHODS  
A cross sectional study was conducted at Yekatit 
12 Hospital Burn Center; Addis Ababa, Ethiopia 
from April to July 2010.  Ten milliliters of blood 
specimen was collected from the fore arm after 
cleaning with 70% alcohol. Then, the needle used 
for collection was replaced by new sterile needle 
for dispensing into culture bottles. The blood 
specimens were inoculated into a trypton soya 
broth, and incubated at aerobic and anaerobic 
conditions (using anaerobic gas generating kits). 
The inoculated bottles were inspected daily for a 
sign of growth (hemolysis, turbidity, surface 
growth), and sub-cultured on blood agar (Oxoid) 
and MacConckey agar (Oxoid) when there was a 
sign of growth to isolate  pure colony. Finally, the 
bottle with no growth after seven days was sub-
cultured on blood agar and MacConckey in a 
similar way like bottles showing growth, and 
rejected if there was no growth after sub-culture.  
After isolation of the pure colony, further 
biochemical identifications were done by 
conventional methods.  
Sufficient wound swabs were also collected. 
Wound swabs were inoculated on (blood agar, 
MacConckey, and Mannitol salt agar (Oxoid) and 
incubated for 24 hours. Each identified growth 
was characterized biochemically. Antimicrobial 
susceptibility patterns for each isolate were 
determined by disk diffusion (Kirby-Bauer 
technique) on Muller Hinton agar (Oxoid) for the 
commonly prescribed drugs at the Burn Center.  
The bacterial isolates were tested against the 
following drugs commonly used at the Burn 
Center; Ampicillin (10µg), Amoxicillin (30µg), 
Gentamycin (5µg), Penicillin G (10IU), 
Methicillin (5µg), Amoxicillin/clavulinic (20µg), 
Sulphomethaxazole/trimethprime (25 µg), 
Norfloxacin (10 µg), Ciprofloxacin (5 µg) and 
Nalidixic acid (30 µg) (Oxoid). The data was 
analyzed by using SPSS version16 statistical 
software for descriptive statistics. 
The specimen was collected after the study 
was approved by the Ethics Committee of Addis 
Ababa University-Institutional Review Board 
(AAU-IRB); and written consent was obtained 
from the study participants and from parents or 
legal guardians for study participants under the 
age of 18. 
Patients under critical condition, unconscious 
patients and patients who were not willing to 
participate in the study were not included in the 
study.   
 RESULTS  
A total of 50 burn patients who either visited or 
were admitted to the Burn Center during the data 
collection period were included in the study. Both 
blood and wound swab samples were collected 
from all study subjects. Of the total study 
participants, females accounted for 20(40%) and 
males accounted for 30 (60%), whereas the age 
ranged from 7 years to 55years with the mean and 
median ages of 26.24 years and 24.5 years 
respectively. 
The magnitude of bacteremia among burn 
patients at the center was 21(42%). Five different 
bacterial species were isolated; Coagulase 




negative staphylococci and Staphylococcus aureus 
were most common. The distribution of these 
isolates ranged between Coagulase negative 
staphylococci, 9(42.8%), S. aureus, 8(38.2%), 
Bacillus spps 2(9.52%), and both Klebsella 
pneumoniae and Pseudomonas aeruginosa, 
2(4.8%), (Table1). 
 
Table 1: Magnitude and types of bacteria isolated 
from the blood culture of burn patients at the 
Yekatit12 Hospital Burn Unit, Addis Ababa, 
Ethiopia (July 2010). 
 
 
Bacterial agents were isolated from 39 of 50 
wound swabs. The total bacterial isolates were 47 
and were identified as; S.aureus and P. aeruginosa 
were predominant isolates, 16(34.04%), and 
15(31.8%), respectively, followed by Coagulase 
negative Staphylococci 6(12.76%), Proteus 
vulgaris 4(8.5%), Proteus mirabilis 4(8.5%), 
Klebsella pneumoniae 1(2.1%), and Providencia 
spps 1(2.1%).  Polymicrobial colonization of the 
wound was seen in 7/39 (17.94%) wound samples 
(Table 2). 
 
Table 2: Distribution and types of the bacterial 
isolates from the burn wound swab of burn 
patients at the Yekatit 12 Hospital Burn Center, 
Addis Ababa, Ethiopia (May- July 2010). 
 
 
The total bacteria identified in this study both 
from blood and wound were 68 both at inpatient 
and outpatient care services. The distribution of 
these species varies with S. aureus 24(35.3%), P. 
aeruginosa 16(23.5%), Coagulase negative 
Staphylococci 15(22.1%), P. mirabilis 4(5.9%), P. 
vulgaris 4(5.9%), Bacillus species 2(2.9%), K. 
pneumoniae 2(2.9%)   and Providencia spps 
1(1.5%) (Table 3).    
 
Table 3: Distribution and magnitude of the 
bacterial isolates both from the burn wound swab 
and blood culture from burn patients at the Yekatit 
12 Hospital Burn Center, Addis Ababa, Ethiopia 
(May– July, 2010). 
 
Types of isolates Number (%) 
S. aureus  24(35.5) 




Proteus mirabilis  4 (5.9) 
Proteus vulgaris  4(5.9) 
Bacillus species  2(2.9) 
Klebsiella pneumoniae  2(2.9) 
Providencia spps   1(1.5) 
Total  68(100) 
 
With regard to the antimicrobial 
susceptibility/sensitivity pattern, all the isolates 
were tested against the following commonly 
prescribed drugs at the center and widely used in 
the country: Norfloxacin, Augmentin, Nalidixic 
acid, Penicillin G, Gentamycin, Ceftriaxone, 
Doxycycline, Ampicillin, Methicillin, and 
Tetracycline. Among the tested drugs, Norfloxacin 
was not found to have resistance and shown 
intermediate resistance to one isolate only; 
Nalidixic acid (77.4%), Ampicillin (76.1%), 
Doxycycline (74.1%), Penicillin G (68.3%) and 
Tetracycline (67.8%), had the highest resistance 
(Table 4). 
Some of the possible risk factors for 
bacteremia like the total body surface area 
(TBSA) burn, prior antibiotic use, medical care 
service and area of residence were recorded. All 
the bacteremia cases, 21(100%), were isolated 
from the 42 patients with the TBSA of ≥15%; 
38/42 (90.4%) patients who were positive for 
wound swab culture were also from the group of 
patients with TBSA ≥ 15%. Other factors like 
Types of isolates  Number (%) 
Coagulase negative staphylococci 9(42.8) 
Staphylococcus aureus  8(38.2) 
Bacillus spps 2(9.52) 
Pseudomonas aeruginosa  1(4.8) 
Klebsiella pneumoniae  1(4.8) 
Total  21(100) 
Types of isolates Number 
(%) 
Staphylococcus aureus  16(34.04) 
Pseudomonas aeruginosa  15(31.8) 
Coagulase negative Staphylococci 6(12.76) 
Proteus mirabilis  4(8.5) 
Proteus vulgaris  4(8.5) 
Klebsiella pneumoniae  1(2.1) 
Providencia spps  1(2.1) 
Total  47(100) 





prior systemic antibiotics use showed relatively 
decreased proportion of bacteremia 5/14(35.7 %) 
as compared to non users16/36 (44.4%).The 
proportion of wound swab isolates both among the 
groups of patients who had used antibiotic before 
coming to the center and those who had not used 
remained more or less similar 11/14 (78.5%) and 
28/36 (77.7%), respectively. 
 
Table 4: Antimicrobial sensitivity/susceptibility pattern of the bacterial isolates both from the burn wound 
swab and blood culture from burn patients at the Yekatit 12 Hospital Burn Center, Addis Ababa, Ethiopia 
(May-July, 2010). 
 
R = resistance; S= sensitive; I = intermediate, - = not tested1; PM=   Proteus mirabilis, PV = Proteus vulgaris, S. a = 




The burn wound management and critical care 
medicine has accelerated a lot and is still 
developing with new generation tools being 
innovated. In burn patient care, bacteremia and /or 
septicemia is the major problem in burn patients. 
This study was conducted to determine the 
bacteriological profile and magnitude of 
bacteremia and has demonstrated 42% bacteremia. 
Bacterial isolates identified were Coagulase 
negative staphylococci (42.8%), S. aureus (38.2%) 
Bacillus spps (9.5%), P. aeruginosa (4.8%), and 
K. pneumoniae (4.8%); these isolates were similar 
to bacterial isolates identified at other different 
burn centers (6, 11, 12).   
Antimicrobial agent tested                                                        Types isolates  
Norfloxacin 
 

















 N (%) 
R - - 0 0 0 0 0 - 0(0) 
S - - 1 4 4 1 16 - 26(96.3) 
I - - 1 0 0 0 0 - 1(3.7) 
Amoxicillin/clavulinic acid R 2 0 0 2 3 1 13 3 24(37.5) 
S 0 14 2 2 1 0 1 19 39(60.9) 
I 0 0 0 0 0 0 0 1 1(1.5) 
Nalidixic acid  R 2 12 1 1 0 0 14 18 48(77.4) 
S 0 0 1 3 4 1 2 1 12(19.4) 
I 0 2 0 0 0 0 0 0 2(3.2) 
Penicillin G R 2 3 - - - - - 23 28(68.3) 
S 0 8 - - - - - 0 8(19.5) 
I 0 4 - - - - - 1 5(12.2) 
Gentamycin  R 0 1 1 1 0 0 2 8 13(19.3) 
S 2 14 1 2 4 1 10 14 48(70.5) 
I 0 0 0 1 0 0 4 2 7(10.2) 
Ceftriaxone  R - - 1 1 0 0 3 - 5(18.5) 
S - - 1 3 4 0 7 - 15(55.5) 
I - - 0 0 0 1 6 - 7(25.9) 
Doxycycline  R - - 1 3 4 0 12 - 20(74.1) 
S - - 1 1 0 1 3 - 6(22.2) 
I - - 0 0 0 0 1 - 1(3.7) 
Ampicillin  R 2 2 1 4 3 1 13 22 48(76.2) 
S 0 10 1 0 1 0 0 1 13(20.6) 
I 0 2 0 0 0 0 0 0 2(3.2) 
Methicillin  R 2 5 - - - - - 5 12(29.2) 
S 0 9 - - - - - 17 26(63.4) 
I 0 1 - - - - - 2 3(7.4) 
Tetracycline  R 0 7 - - - - - 17 25(67.5) 
S 1 5 - - - - - 5 11(29.7) 
I 1 0 - - - - - 0 1(2.7) 




 Current definitions of sepsis and infection have 
many criteria (fever, tachycardia, tachypenia, and 
leukocytosis) that are routinely found in patients 
with extensive burns, making the current 
definition less applicable to the burn population 
(20, 21). This study has come up with bacteremia 
without having significant symptoms of sepsis 
according to the definition; which is still the 
terminal risk of sepsis and septic complications. 
Yet, it may seem clinically non-indicative but later 
when the bacterial number in the circulation is 
maintained at higher load, there could be an abrupt 
onset of the clinical sepsis that may accelerate to 
septic shock with poor prognosis. Delayed clinical 
symptoms of sepsis in the presence of bacteremia 
might be because of immunosuppression 
secondary to thermal injury. As another study (22) 
indicated temperature, white blood cell count, 
neutrophil percentage, or changes in these values 
were not clinically reliable in predicting blood 
stream infections. Further work is needed to 
identify the alternative clinical parameters which 
should prompt blood culture evaluation among the 
burn patient population.        
Although the frequency of isolation is 
different from one burn center to the other, the 
bacteria profile remains similar. Generally, from 
both blood and wound swab, 68 bacterial isolates 
were isolated and characterized; these include:  S. 
aureus (35.5%), P. aeruginosa (23.5%), 
Coagulase negative staphylococci, (22.1%), 
Proteus vulgaris and Proteus mirabilis (5.9%) 
each, Bacillus spps (2.9%), Klebsella pneumonia, 
(2.9%) to Providencia spps (1.5%). When  
compared to one of the study (23) done at a 
tertiary care hospital in India, the isolates were all 
aerobic bacteria in a similar manner and 
predominantly S aureus and P. aeruginosa 
accounting for 75% and they were multidrug 
resistant.  
On the other hand, isolates from wound 
swabs were analyzed separately and hence the 
most common isolates from the wound swab 
include S. aureus (34.04%), followed by P. 
aeruginosa (31.5%), Coagulase negative 
staphylococci (12.76%), Proteus mirabilis (8.5%), 
Proteus vulgaris (8.5%), K. pneumoniae (2.1%), 
and Providencia spps (2.1%). Although a number 
of studies have been conducted on burn wound 
infection and bacterial profile, nearly all of them 
are retrospective studies which made comparison 
of findings of this study to those findings difficult; 
however, these studies remain optional for 
comparison. Comparison of bacterial isolates with 
other studies may also be difficult because of 
geographical variations, drug policies, infection 
control policies and the like (23, 24). Furthermore, 
particularly the resistant strains vary even between 
different intensive care units of the same 
institution (1). 
The bacterial isolates in this study are more 
or less similar to the bacterial profile identified at 
Ain Shams University Hospital, Cairo (9). There 
is no anaerobic bacterium identified in this study 
which is also similar to the above mentioned 
study. Other studies (23, 25) have also indicated 
that anaerobic infections are rare.  Rate of MRSA 
(7.3%) is low as compared to a study (7) from 
India has shown that the dominant cause of wound 
infection is MRSA (71%).  
Of the drugs tested against these isolates, all 
the isolates were sensitive to Norfloxacin, except 
one organism K. pneumoniae which is 
intermediate. This study has shown a very high 
incidence of resistance to the drugs like Nalidixic 
acid (77.4%), Ampicillin (76.2%), Doxycycline 
(74.1%), and Penicillin G (68.3%), Tetracycline 
(67.8%), Augumentin (37.5%), Methicillin 
(29.5%), Gentamycin (19.1%), and Ceftriaxone 
(18.5%) to the isolates identified at the burn 
center. Moreover, around 82.3% of the isolates 
were resistant to two or more of the drugs tested, 
demonstrating multiple drug resistance except for 
Norfloxacin.  
Another serious problem at the critical care 
units is MRSA which is increasing from time to 
time and causes increased cost (26). The MRSA 
incidence in the present study is (7.3%), although 
it is lower compared to a study in India (71%) (7), 
yet it is a critical problem in developing countries 
where drug spectrum is limited. This significant 
difference might be the result of the difference in 
epidemiological parameters of MRSA and might 
also be because of drug policy. In addition, the 
period of study and sample size might also cause 
the difference. The increase in Coagulase negative 
staphylococci isolates was significant because it 
might be associated with Methicillin resistant 
Coagulase negative staphylococci strains. 
Coagulase negative staphylococci is recognized to 
be equally pathogenic as S. aureus in immune 
suppressed subjects such as thermal injuries and 





often deliver its genetically resistant codes to 
previously liable S.aureus which subsequently 
turns in to MRSA (24). This might be why MRSA 
and Methicillin resistant Coagulase negative 
staphylococci increase concomitantly. Another 
study has determined that death related to bacterial 
blood stream infection is commonly because of S. 
aureus early in the hospital course (27).   
The higher incidence of resistant isolates 
could be because of the inappropriate use of 
antibiotics. To the knowledge of investigators, 
there are no antibiotic use policies and infection 
control units in any of the care centers or health 
institutions in the country. Despite the fact that S. 
aureus and other common bacterial agents are 
similar at different burn centers; the antimicrobial 
sensitivity pattern cannot be compared between 
these centers because of difference in different 
prescription patterns and may be because there is 
no standardized prescription and management 
scheme common to all. However, the antibiotic 
treatment should be changed in accordance with 
the observed antibiotic susceptibility pattern in 
case of positive blood cultures and signs of sepsis. 
Because of the insufficient supply of drugs, the 
antimicrobial treatment choice and changes has to 
be made to the wise utilization of what is available 
at the time.                                       
The total body surface area (TBSA) of the 
burn; a TBSA of ≥ 15% cut off value as a major 
burn was considered a risk factor for bacteremia. 
All cases of bacteremia (100%) in this study were 
isolated from patients having TBSA of burn 
≥15%.  The higher the total body surface area 
damaged by the thermal assault the higher the 
potential for the bacteria to colonize and 
proliferate increasing the wound thickness and 
depth making way to the blood stream 
involvement.             
Bacteremia was found among the burn 
patients at a magnitude of 42% at the burn center. 
The most common isolates at this center were S. 
aureus and P. aeruginosa. Almost all isolates 
were multiple drug resistant isolates; 82% of the 
isolates showed resistance to at least two or more 
of the drugs tested. Tetracycline, Ampicillin and 
Nalidixic acid were the drugs to which higher 
percentage of resistance has been seen among the 
tested drugs whereas Norfloxacin was the only 
drug to which all isolates tested were found 
sensitive. Risk factors associated with bacteremia 
were TBSA of burn ≥15%, area of residence; 
being from rural area has showed higher 
proportion of wound infection isolates. Prior 
systemic antibiotic use was also found to decrease 
risk of bacteremia but has no effect on wound 
infection.  
Bacteremia goes undetectable at a rate of 
42% among burn patients at Yekatit-12 Hospital 
Burn Unit. The most common bacterial isolates 
were Coagulase negative staphylococci and 
Staphylococcus aureus. The distribution of these 
isolates ranges between Coagulase negative 
staphylococci, 9(42.8%), S. aureus, 8(38.2%), 
Bacillus spps, 2(9.52%), and both Klebsella 
pneumoniae and Pseudomonas aeruginosa, 
2(4.8%). Total body surface area of burn (TBS) 
greater than 15% was found to be the risk factor 
for bacteremia. 
Bacterial isolates identified from wound swab 
were 47; S.aureus and P. aeruginosa were 
predominant isolates, 16(34.04%), and 15(31.8%), 
respectively, followed by Coagulase negative 
Staphylococci 6(12.76%), P. vulgaris 4(8.5%), P. 
mirabilis 48.5%), K. pneumoniae 1(2.1%), and 
Providencia spps 1(2.1%).  Polymicrobial 
colonization of the wound was seen from 7/39 
(17.94%) wound samples. 
Among the tested drugs, Norfloxacin was not 
found to have resistance and shown intermediate 
only for one isolate. Nalidixic acid, (77.4%), 
Ampicillin, (76.1%), Doxycycline, (74.1%), 
Penicillin G, (68.3%), and Tetracycline, (67.8%), 
have the highest resistance. And 82.16% of the 
isolates in this study showed multiple resistances 
(at least two or more of antibiotics tested).  
For burn patient care, bacteriological blood 
culture, wound swab culture and antimicrobial 
susceptibility pattern of isolates should be done 
for each patient under ideal conditions. However, 
this is not possible for resource limited countries, 
and hence, periodic surveillance of the burn unit 
isolates should be done to know commonly 
circulating isolates. This helps clinicians to 
consider appropriate antimicrobial agents in hand 
when empirical treatment is a mandatory option in 
critical situations, which is a common practice in 
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